| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15.9M | +4.6% | +24.8% |
| Cost of Revenue | $13.2M | -2.2% | +10.5% |
| R&D Expense | $9K | -18.2% | +0.0% |
| SG&A Expense | $1.7M | -1.6% | +36.3% |
| Operating Income | -$153K | +84.3% | +90.3% |
| Pre-tax Income | -$154K | +84.2% | +90.3% |
| Income Tax | $0 | — | -100.0% |
| Net Income | -$154K | +84.2% | +90.3% |
| EPS (Basic) | -$0.01 | +75.0% | +83.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.4M | +24.4% | +497.2% |
| Accounts Receivable | $8.0M | +29.9% | +37.0% |
| Current Assets | $11.7M | +26.9% | +75.6% |
| Total Assets | $24.7M | +9.4% | +19.7% |
| Current Liabilities | $8.8M | +12.6% | +57.3% |
| Total Liabilities | $8.9M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.4M | — | — |
| Capital Expenditures | $22K | — | — |
| Investing Cash Flow | -$22K | — | — |
| Free Cash Flow | $2.3M | — | — |
| +59.1% |
| Stockholders' Equity | $15.8M | +7.1% | +5.0% |